| Entry |
|
|---|
| Name |
Budesonide (JP18/USP/INN);
Entocort EC (TN);
Pulmicort (TN);
Rhinocort (TN);
Uceris (TN) |
|---|
| Product |
|
|---|
| Generic |
BUDESONIDE (Actavis Pharma), BUDESONIDE (American Health Packaging), BUDESONIDE (American Health Packaging), BUDESONIDE (Amneal Pharmaceuticals LLC), BUDESONIDE (Bryant Ranch Prepack), BUDESONIDE (Bryant Ranch Prepack), BUDESONIDE (Cardinal Health 107), BUDESONIDE (Cipla USA), BUDESONIDE (ENTERIC COATED) (Golden State Medical Supply), BUDESONIDE (ENTERIC COATED) (Mayne Pharma), BUDESONIDE (Exelan Pharmaceuticals), BUDESONIDE (Golden State Medical Supply), BUDESONIDE (Major Pharmaceuticals), BUDESONIDE (Mylan Pharmaceuticals), BUDESONIDE (Nephron Pharmaceuticals Corporation), BUDESONIDE (NorthStar RxLLC), BUDESONIDE (Northstar Rx LLC.), BUDESONIDE (Oceanside Pharmaceuticals), BUDESONIDE (Preferred Pharmaceuticals), BUDESONIDE (Preferred Pharmaceuticals), BUDESONIDE (Rising Pharmaceuticals), BUDESONIDE (Sandoz), BUDESONIDE (Sun Pharmaceutical Industries), BUDESONIDE (Teva Pharmaceuticals USA), BUDESONIDE (Teva Pharmaceuticals USA), BUDESONIDE (Teva Pharmaceuticals USA), BUDESONIDE (Zydus Lifesciences Limited), BUDESONIDE (Zydus Pharmaceuticals USA), BUDESONIDE INHALATION (American Health Packaging), BUDESONIDE INHALATION (Amneal Pharmaceuticals of New York LLC), BUDESONIDE INHALATION (Lupin Pharmaceuticals), BUDESONIDE INHALATION SUSPENSION (Ritedose Pharmaceuticals) |
|---|
| Formula |
C25H34O6
|
|---|
| Exact mass |
430.2355
|
|---|
| Mol weight |
430.5339
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Product (mixture): | D09595<JP/US> D11584<JP/US> |
|
|---|
| Efficacy |
Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist |
|---|
| Disease |
Asthma [DS: H00079] Crohn's disease [DS: H00286] Perennial allergic rhinitis [DS: H01360] Distal ulcerative colitis [DS: H01466] |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EA Corticosteroids acting locally
A07EA06 Budesonide
D00246 Budesonide (JP18/USP/INN) <JP/US>
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AC Corticosteroids, potent (group III)
D07AC09 Budesonide
D00246 Budesonide (JP18/USP/INN) <JP/US>
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD Corticosteroids
R01AD05 Budesonide
D00246 Budesonide (JP18/USP/INN) <JP/US>
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BA Glucocorticoids
R03BA02 Budesonide
D00246 Budesonide (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Budesonide
D00246 Budesonide (JP18/USP/INN)
Inflammatory Bowel Disease Agents
Glucocorticoids
Budesonide
D00246 Budesonide (JP18/USP/INN)
Respiratory Tract/Pulmonary Agents
Anti-inflammatories, Inhaled Corticosteroids
Budesonide
D00246 Budesonide (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D00246 Budesonide (JP18/USP/INN)
23 Digestive organ agents
239 Miscellaneous
2399 Others
D00246 Budesonide (JP18/USP/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
D00246 Budesonide
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D00246 Budesonide
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D00246 Budesonide
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D00246 Budesonide (JP18/USP/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00246
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00246
Rx-to-OTC switch list in the USA [br08315.html]
D00246
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 31
1 C2x C 16.6600 -25.0600
2 C5x C 16.6600 -26.4600
3 C2x C 17.8500 -27.1600
4 C2y C 19.1100 -26.4600
5 C1z C 19.1100 -25.0600
6 C2x C 17.8500 -24.3600
7 C1x C 20.3000 -27.1600
8 C1x C 21.4900 -26.4600
9 C1y C 21.4900 -25.0600
10 C1y C 20.3000 -24.3600
11 C1y C 22.7500 -24.3600
12 C1z C 22.7500 -22.9600
13 C1x C 21.4900 -22.2600
14 C1y C 20.3000 -22.9600
15 C1x C 25.1300 -24.3600
16 C1y C 25.1300 -22.9600
17 C1z C 23.9400 -22.2600
18 O5x O 15.4700 -27.1600
19 C1a C 19.1100 -23.6600
20 O1a O 19.1100 -22.2600
21 C1a C 22.7500 -21.5600
22 C5a C 23.9400 -20.7200
23 O2x O 25.1300 -21.5600
24 O2x O 26.5300 -22.6100
25 C1y C 26.5300 -21.5600
26 C1b C 27.7200 -20.8600
27 C1b C 28.9100 -21.5600
28 C1a C 30.1000 -20.8600
29 O5a O 25.1524 -20.0200
30 C1b C 22.7276 -20.0200
31 O1a O 21.5321 -20.7104
BOND 35
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 2 18 2
22 5 19 1 #Up
23 14 20 1 #Up
24 12 21 1 #Up
25 17 22 1 #Up
26 17 23 1 #Down
27 16 24 1 #Down
28 23 25 1
29 25 24 1
30 26 27 1
31 26 25 1
32 27 28 1
33 22 29 2
34 22 30 1
35 30 31 1
|
|---|
|
